药效评价SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.
期刊:British journal of pharmacology发表年份:2009作者:M E Bradley; M E Bond; J Manini; Z Brown; S J Charlton
追踪行业前沿,洞察产业趋势